Ws Management Lllp Crispr Therapeutics Ag Transaction History

Ws Management Lllp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$110.72 - $210.04 $106,734 - $202,478	-964 Reduced 4.86%	18,876 $2.3 Million
Q2 2020 Aug 13, 2020	SELL	$38.5 - $76.05 $131,362 - $259,482	-3,412 Reduced 14.67%	19,840 $1.46 Million
Q1 2020 May 13, 2020	SELL	$33.68 - $62.53 $39,338 - $73,035	-1,168 Reduced 4.78%	23,252 $986,000
Q3 2019 Nov 13, 2019	SELL	$40.99 - $52.56 $110,345 - $141,491	-2,692 Reduced 9.93%	24,420 $1 Million
Q2 2019 Aug 13, 2019	SELL	$35.45 - $48.2 $113,581 - $154,432	-3,204 Reduced 10.57%	27,112 $1.28 Million
Q1 2019 May 13, 2019	SELL	$28.02 - $40.87 $114,349 - $166,790	-4,081 Reduced 11.86%	30,316 $1.08 Million
Q4 2018 Feb 12, 2019	SELL	$22.73 - $42.34 $513,766 - $957,011	-22,603 Reduced 39.65%	34,397 $983,000
Q2 2018 Aug 13, 2018	BUY	$42.62 - $73.59 $2.43 Million - $4.19 Million	57,000 New	57,000 $3.35 Million

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.